FCRM Projects

The Fondation Congolaise pour la Recherche Médicale (FCRM) is a private research institution in Brazzaville, Republic of Congo, dedicated to conducting epidemiological and clinical studies on major public health challenges such as malaria, HIV/AIDS, and tuberculosis.

Projects

Through its commitment to applied research and public health impact, the Fondation Congolaise pour la Recherche Médicale (FCRM) has led and contributed to numerous projects aimed at addressing major health challenges in Central Africa. These initiatives span clinical research, disease surveillance, community-based interventions, and health system strengthening. Each project reflects FCRM’s mission to generate evidence-based solutions, foster innovation, and support national and regional efforts to control and eliminate neglected tropical diseases. The following projects highlight the Foundation’s diverse contributions to advancing scientific knowledge and improving population health.

PANDORA-ID Net

Preparedness and responses to infectious diseases outbreaks in Africa

Strengthening health research capacities in Central Africa institutions

Project aiming at understanding Ebola virus infection in survivors

Main contact person

Based in Brazzaville, Republic of the Congo, the Fondation Congolaise pour la Recherche Médicale (FCRM) is a private, non-profit organisation dedicated to scientific research, training, and innovation, with the goal of enhancing public health. FCRM conducts epidemiological and clinical studies on diseases such as malaria, HIV/AIDS, and tuberculosis, contributing significantly to the understanding and control of these conditions.

Professor Francine Ntoumi, Founder, President, and Executive Director of FCRM, serves as the principal contact for the EMINENCE project, overseeing the institution’s scientific contributions and strategic engagement within the consortium.

About Us

The EMINENCE project is dedicated to eliminating onchocerciasis in Africa through innovative clinical research and the evaluation of moxidectin to enhance disease control and accelerate eradication efforts.

© EMINENCE - EDCTP. All rights reserved

Scroll to Top